UT
United Therapeutics Corporation
🇺🇸XNAS.UTHRUnited StatesHealthcare
$503.85USDup +1.15 (+0.23%)OpenEnd of day4:16 PM
Price$503.85+1.15 (+0.23%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US91307C1027
- CUSIP
- 91307C102
Company
- Employees
- 1,400
- Headquarters
- Silver Spring, United States
- Website
- https://www.unither.com
- CEO
- Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.
Market
- Shares outstanding
- 42.9M
- Market cap
- $21.61B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $21.61B
- EPS LTM
- $30.56calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 16.49calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3.15B+2.49%up year on year
- Net income
- $1.31B+5.54%up year on year
- Gross margin
- 86.14%-3.19%down year on year
- Free cash flow
- $1.09B+2.05%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.